Business Team

Careers @ Myeloid

Want to be part of a team that's making big strides in solving big human health problems?  Consider reaching out to see if we're a good fit.  

Myeloid Kind of People

"Discovery consists of looking at the same thing as everyone else and thinking something different"

 

- Albert Szent-Gyorgyi

Passion 

for scientific inquiry and  dedication to solving big problems

Selfless & 

relentless collaboration

Creativity &

flexibility in the face of challenges

Accountability &

a commitment to excellence

Working inter-professionally/personally to create meaningful human health solutions

DISCOVERY

RESEARCH

Yuxiao Wang, PhD 

Kyong-Rim Kieffer-Kwon, PhD

Neha Diwanji, PhD

Ty Chu, PhD

Hongyun Zhao, PhD

Ty Chu, PhD

CMC &

MANUFACTURING

Caitlyn Harvey

James Collins

Harshal Zope PhD

Patrick Tavares

Rajat Saggar

MOLECULAR &

RNA SCIENCES

Inna Shcherbakova, PhD

Tyler Nicholson

Marie Didiot, PhD

Bill Rowley

Soki Ly, PhD

CLINICAL DEVELOPMENT & OPERATIONS

Sophia Mansora

Hannah Crowell

Tommy Chang

Malin Deon

TRANSLATIONAL IMMUNOLOGY

Thomas Prod'homme, PhD 

Chetan Rane, PhD

Michael Gorgievski

Ed Cochran

Jodie D’Alessandro

Myeloid Therapeutics is an immunology company focused on combining biology insights with cutting-edge technologies to harness myeloid cells and eradicate cancer and other diseases. With broad clinical applications possible, the Company is presently advancing its cell therapy product candidates, derived from its ATAKTM platform technology, with initial applications in T cell lymphoma and a primed monocyte approach to treating glioblastoma. The ATAK platform is scalable to multiple treatment modalities and to other disease areas in collaboration. Myeloid expects to enter the clinic with its two lead programs in the first half of 2021. The company, having operations in Cambridge, MA, was founded by Ronald Vale and Siddhartha Mukherjee.